Lexaria Bioscience Corp. (NASDAQ:LEXX) | Finanzwire

Basculer en Français

10411	Companies
217811	Keywords
147360	Articles
115249	Press releases

Headlines Articles Press releases Lexaria Bioscience Corp.

Home
Companies
Lexaria Bioscience Corp.

BRIEF

published on 12/23/2025 at 15:34, 4 months 23 days ago

Lexaria's Phase 1b Study Achieves Primary Endpoint

Drug Delivery Innovation Phase 1b Study Lexaria Bioscience DehydraTECH-semaglutide Side Effect Reduction
PRESS RELEASE

published on 12/23/2025 at 15:29, 4 months 23 days ago

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Lexaria Bioscience Corp. announces DehydraTECH-semaglutide shows significant reduction in gastrointestinal side effects compared to Rybelsus®, with recent financings enabling new 2026 development opportunities

Financings DehydraTECH-semaglutide Lexaria Bioscience Corp. Rybelsus Gastrointestinal Side Effects
PRESS RELEASE

published on 09/21/2023 at 15:10, 2 years 7 months ago

Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD

Accesswire

Published on 05/16/2026 at 01:15, 1 hour 52 minutes ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 2 hours 7 minutes ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 3 hours 7 minutes ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 3 hours 57 minutes ago

Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 4 hours 7 minutes ago

Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE

EQS Group

Published on 05/15/2026 at 20:10, 6 hours 57 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 8 hours 37 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 8 hours 56 minutes ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 9 hours 33 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 16:48, 10 hours 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/15/2026 at 15:08, 11 hours 59 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 18:00, 2 days 9 hours ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 17:45, 2 days 9 hours ago

Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 2 days 9 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 2 days 9 hours ago

Report on share repurchases from 6 to 12 May 2026

View all LES ECHOS COMFI WIRE